MPM Oncology Impact Management »

Karuna Therapeutics Ord shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.0M 53k 169.09
2023-06-30 $12M 53k 216.85
2022-06-30 $2.5M 20k 126.50
2022-03-31 $2.5M 20k 126.80

More positions owned by MPM Oncology Impact Management

Cullinan Oncology Common (CGEM)
Olema Pharmaceuticals Common (OLMA)
Geron Corporation Common (GERN)
Repare Therapeutics Common (RPTX)
iTeos Therapeutics Common (ITOS)
Intellia Therapeutics Common (NTLA)
Moonlake Immunotherapeutics Common (MLTX)
Iovance Biotherapeutics Common (IOVA)
Crinetics Pharmaceuticals Common (CRNX)
Insmed Incorporated Common (INSM)
Structure Therapeutics Common (GPCR)
Verve Therapeutics Common (VERV)
Relay Therapeutics Common (RLAY)
Regenxbio Common (RGNX)
Cymabay Therapeutics Common

View all positions for MPM Oncology Impact Management

Top funds holding Karuna Therapeutics Ord

T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Avidity Partners Management
Goldman Sachs Group
Eventide Asset Management
Millennium Management
CNH Partners

View all funds holding Karuna Therapeutics Ord